HEPARIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Heparin, and when can generic versions of Heparin launch?
Heparin is a drug marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, Solopak, Abraxis Pharm, Aspen Global Inc, B Braun Medical Inc, Be Pharms, Casi Pharms Inc, Chamberlin Parenterl, Dell Labs, Dr Reddys, Epic Pharma Llc, Fresenius Kabi Usa, Gland, Hikma, Hospira Inc, Lilly, Mylan Labs Ltd, Nanjing King-friend, Pfizer, Pharm Spec, Pharmacia And Upjohn, Sagent Pharms, Sandoz, Shenzhen Techdow, Watson Labs Inc, Baxter Hlthcare, Mcgaw, B Braun, and Pharma Serve Ny. and is included in eighty-four NDAs.
The generic ingredient in HEPARIN is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Heparin
A generic version of HEPARIN was approved as heparin sodium by HOSPIRA on April 28th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HEPARIN?
- What are the global sales for HEPARIN?
- What is Average Wholesale Price for HEPARIN?
Summary for HEPARIN
| US Patents: | 0 |
| Applicants: | 33 |
| NDAs: | 84 |
| Drug Prices: | Drug price information for HEPARIN |
| DailyMed Link: | HEPARIN at DailyMed |
US Patents and Regulatory Information for HEPARIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 017037-002 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Parke Davis | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 017346-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 017064-015 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chamberlin Parenterl | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 017130-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% | heparin sodium | INJECTABLE;INJECTION | 018911-008 | Jan 30, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | heparin sodium | INJECTABLE;INJECTION | 018916-011 | Jun 23, 1989 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Lilly | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 005521-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
